<DOC>
	<DOCNO>NCT00617123</DOCNO>
	<brief_summary>This study design evaluate long-term ocular safety SCH 530348 ( vorapaxar ) participant establish atherosclerotic disease enrol TRA 2°P - TIMI 50 Study ( P04737 ) ( NCT00526474 ) .</brief_summary>
	<brief_title>Trial Assess Ocular Safety Vorapaxar ( SCH 530348 ) Participants With Atherosclerosis ( Study P05183 )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Vorapaxar</mesh_term>
	<criteria>Evidence history atherosclerosis involve coronary , cerebral , peripheral vascular system The study include participant meet none exclusion criterion parent protocol ( P04737 ) also follow : history evidence agerelated macular degeneration baseline evaluation history diabetic macular edema , evidence treat diabetic retinopathy baseline evaluation history evidence retinal disease , include retinal injury , baseline evaluation history evidence retinal surgery , include laser photocoagulation , baseline evaluation history evidence glaucoma baseline evaluation history evidence high intraocular pressure &gt; 22 mm Hg baseline evaluation evidence center foveal thickness &gt; 190 µm baseline OCT examination presence vacuole retina baseline OCT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>